{
    "2021-07-30": [
        [
            {
                "time": "2023-08-01",
                "original_text": "What's in Store for Amgen (AMGN) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Amgen",
                        "earnings season",
                        "expectations"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-08-01",
                "original_text": "Eli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2 earnings",
                        "report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-08-01",
                "original_text": "Pharma Stock Roundup: Q2 Earnings of MRK, PFE & Others, FDA Approvals for GSK, ABBV",
                "features": {
                    "keywords": [
                        "pharma stock",
                        "Q2 earnings",
                        "FDA approvals",
                        "MRK",
                        "PFE",
                        "GSK",
                        "ABBV"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-08-01",
                "original_text": "Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease",
                "features": {
                    "keywords": [
                        "Donanemab",
                        "Alzheimer's",
                        "biomarkers",
                        "early disease"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}